Home > > North America And Global Gene Therapy Market- Size, Share, Growth Rate, and Forecast
The North America Gene Therapy market was valued at $4,100.3 Million in 2023, and is projected to reach $27,421.2 Million by 2030 growing at a CAGR of 31.25% from 2024 to 2030. Non-Viral Vectors segment is expected to be the highest contributor to this market, with $3,363.3 Million in 2023, and is anticipated to reach $18,652.8 by 2030, registering a CAGR of 27.74%. Viral Vectors segment is anticipated to reach $8,768.4 Million by 2030 with the highest CAGR of 41.96%. Vector Non-Viral Vectors Viral Vectors Indication Neurological Diseases Cancer Hepatological Diseases Duchenne Muscular Dystrophy Other Indications Delivery Method In-Vivo Gene Theraoy Ex-Vivo Gene Theraoy BY REGION North America U.s. Canada Europe Germany France U.k. Italy Spain RoE Asia Japan China RoAPAC Middle East & Africa Latin America MEA